-
1
-
-
10244244971
-
Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase
-
Acheampong, A. A., Chien, D.-S., Lam, S., Vekich, S., Breau, A., Usansky, J., Harcourt, D., Munk, S. A., Nguyen, H., Garst, M. and Tang-Liu, D., 1996, Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase. Xenobiotica, 26, 1035-1055.
-
(1996)
Xenobiotica
, vol.26
, pp. 1035-1055
-
-
Acheampong, A.A.1
Chien, D.-S.2
Lam, S.3
Vekich, S.4
Breau, A.5
Usansky, J.6
Harcourt, D.7
Munk, S.A.8
Nguyen, H.9
Garst, M.10
Tang-Liu, D.11
-
2
-
-
0027478959
-
Culture of precision-cut liver slices: Effect of some peroxisome proliferators
-
Beamand, J. A., Price, R. J., Cunninghame, M. E. and Lake, B. G., 1993, Culture of precision-cut liver slices: effect of some peroxisome proliferators. Food and Chemical Toxicology, 31, 137-147.
-
(1993)
Food and Chemical Toxicology
, vol.31
, pp. 137-147
-
-
Beamand, J.A.1
Price, R.J.2
Cunninghame, M.E.3
Lake, B.G.4
-
3
-
-
0023528062
-
Molybdenum hydroxylases: Biological distribution and substrate-inhibitor specificity
-
G. P. Ellis and G. B. West (eds), (Amsterdam: Elsevier)
-
Beedham, C., 1987, Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. In G. P. Ellis and G. B. West (eds), Progress in Medicinal Chemistry, vol. 24 (Amsterdam: Elsevier), pp. 85-127.
-
(1987)
Progress in Medicinal Chemistry
, vol.24
, pp. 85-127
-
-
Beedham, C.1
-
4
-
-
0023577625
-
Species variation in hepatic aldehyde oxidase activity
-
Beedham, C., Bruce, S. E., Critchley, D. J., Al-Tayib, Y. and Rance, D. J., 1987, Species variation in hepatic aldehyde oxidase activity. European Journal of Drug Metabolism and Pharmacokinetics, 12, 307-310.
-
(1987)
European Journal of Drug Metabolism and Pharmacokinetics
, vol.12
, pp. 307-310
-
-
Beedham, C.1
Bruce, S.E.2
Critchley, D.J.3
Al-Tayib, Y.4
Rance, D.J.5
-
5
-
-
0028271564
-
A placebo-controlled evaluation of single, escalating doses of CL-284,846, a non-benzodiazepine hypnotic
-
Beer, B., Ieni, J. R., Wu, W.-H., Clody, D., Amorusi, P., Rose, J., Mant, T., Gaudreault, J., Cato, A. and Stern, W., 1994, A placebo-controlled evaluation of single, escalating doses of CL-284,846, a non-benzodiazepine hypnotic. Journal of Clinical Pharmacology, 34, 335-344.
-
(1994)
Journal of Clinical Pharmacology
, vol.34
, pp. 335-344
-
-
Beer, B.1
Ieni, J.R.2
Wu, W.-H.3
Clody, D.4
Amorusi, P.5
Rose, J.6
Mant, T.7
Gaudreault, J.8
Cato, A.9
Stern, W.10
-
6
-
-
0001013913
-
Species comparison of in vitro and in vivo metabolism of CL-284,846, a non-benzodiazepine sedative/hypnotic agent
-
Chaudhary, I., Demalo, W. and Kantrowitz, J., 1994, Species comparison of in vitro and in vivo metabolism of CL-284,846, a non-benzodiazepine sedative/hypnotic agent. Pharmaceutical Research, 11, S391.
-
(1994)
Pharmaceutical Research
, vol.11
-
-
Chaudhary, I.1
Demalo, W.2
Kantrowitz, J.3
-
7
-
-
77049143386
-
The determination of enzyme inhibitor constants
-
Dixon, M., 1953, The determination of enzyme inhibitor constants. Biochemical Journal, 55, 170-171.
-
(1953)
Biochemical Journal
, vol.55
, pp. 170-171
-
-
Dixon, M.1
-
8
-
-
0014124340
-
Human liver aldehyde oxidase: Differential inhibition of oxidation of charged and uncharged substrates
-
Johns, D. G., 1967, Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates. Journal of Clinical Investigation, 46, 1492-1505.
-
(1967)
Journal of Clinical Investigation
, vol.46
, pp. 1492-1505
-
-
Johns, D.G.1
-
9
-
-
0021715352
-
Elevation of molybdenum hydroxylase levels in rabbit liver after ingestion of phthalazine or its hydroxylated metabolite
-
Johnson, C., Stubley-Beedham, C. and Stell, J. G. P., 1984, Elevation of molybdenum hydroxylase levels in rabbit liver after ingestion of phthalazine or its hydroxylated metabolite. Biochemical Pharmacology, 33, 3699-3705.
-
(1984)
Biochemical Pharmacology
, vol.33
, pp. 3699-3705
-
-
Johnson, C.1
Stubley-Beedham, C.2
Stell, J.G.P.3
-
10
-
-
0022408282
-
Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivo
-
Johnson, C., Stubbley-Beedham, C. and Stell, J. G. P., 1985, Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochemical Pharmacology, 34, 4251-4256.
-
(1985)
Biochemical Pharmacology
, vol.34
, pp. 4251-4256
-
-
Johnson, C.1
Stubbley-Beedham, C.2
Stell, J.G.P.3
-
11
-
-
0032962715
-
Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats
-
Kawashima, K., Hosoi, K., Naruke, T., Shiba, T., Kitamura, M. and Watabe, T., 1999, Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats. Drug Metabolism and Disposition, 27, 422-428.
-
(1999)
Drug Metabolism and Disposition
, vol.27
, pp. 422-428
-
-
Kawashima, K.1
Hosoi, K.2
Naruke, T.3
Shiba, T.4
Kitamura, M.5
Watabe, T.6
-
12
-
-
0030681081
-
Induction of CYP3A isoforms in cultured precision-cut human liver slices
-
Lake, B. G., Ball, S. E., Renwick, A. B., Tredger, J. M., Kao, J., Beamand, J. A. and Price, R. J., 1997, Induction of CYP3A isoforms in cultured precision-cut human liver slices. Xenobiotica, 27, 1165-1173.
-
(1997)
Xenobiotica
, vol.27
, pp. 1165-1173
-
-
Lake, B.G.1
Ball, S.E.2
Renwick, A.B.3
Tredger, J.M.4
Kao, J.5
Beamand, J.A.6
Price, R.J.7
-
13
-
-
0031663160
-
3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices
-
Lake, B. G., Tredger, J. M., Renwick, A. B., Barton, P. B. and Price, R. J., 1998, 3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. Xenobiotica, 28, 803-811.
-
(1998)
Xenobiotica
, vol.28
, pp. 803-811
-
-
Lake, B.G.1
Tredger, J.M.2
Renwick, A.B.3
Barton, P.B.4
Price, R.J.5
-
14
-
-
71849104860
-
Protein measurement with the Folin phenol reagent
-
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
-
(1951)
Journal of Biological Chemistry
, vol.193
, pp. 265-275
-
-
Lowry, O.H.1
Rosebrough, N.J.2
Farr, A.L.3
Randall, R.J.4
-
15
-
-
77956997577
-
Aldehyde oxidase
-
Rajagopalan, K. V. and Handler, P., 1966, Aldehyde oxidase. Methods in Enzymology, 9, 364-368.
-
(1966)
Methods in Enzymology
, vol.9
, pp. 364-368
-
-
Rajagopalan, K.V.1
Handler, P.2
-
16
-
-
0000399088
-
Inhibition of human and guinea-pig liver aldehyde oxidases in-vitro
-
Rashidi, M. R., Smith, J. A., Clarke, S. E. and Beedham, C., 1995, Inhibition of human and guinea-pig liver aldehyde oxidases in-vitro. Journal of Pharmacy and Pharmacology, 47, 1090.
-
(1995)
Journal of Pharmacy and Pharmacology
, vol.47
, pp. 1090
-
-
Rashidi, M.R.1
Smith, J.A.2
Clarke, S.E.3
Beedham, C.4
-
17
-
-
0030840879
-
In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver
-
Rashidi, M. R., Smith, J. A., Clarke, S. E. and Beedham, C., 1997, In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metabolism and Disposition, 25, 805-813.
-
(1997)
Drug Metabolism and Disposition
, vol.25
, pp. 805-813
-
-
Rashidi, M.R.1
Smith, J.A.2
Clarke, S.E.3
Beedham, C.4
-
18
-
-
0031958417
-
Metabolism of zaleplon by human hepatic microsomal cytochrome P450 isoforms
-
Renwick, A. B., Mistry, H., Ball, S. E., Walters, D. G., Kao, J. and Lake, B. G., 1998, Metabolism of zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica, 28, 337-348.
-
(1998)
Xenobiotica
, vol.28
, pp. 337-348
-
-
Renwick, A.B.1
Mistry, H.2
Ball, S.E.3
Walters, D.G.4
Kao, J.5
Lake, B.G.6
-
19
-
-
0028059953
-
Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro
-
Rodrigues, A. D., 1994, Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochemical Pharmacology, 48, 197-200.
-
(1994)
Biochemical Pharmacology
, vol.48
, pp. 197-200
-
-
Rodrigues, A.D.1
-
20
-
-
0027932989
-
The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs. Cynomolgus monkeys, and humans
-
Rodrigues, A. D., Ferrero, J. L., Amann, M. T., Rotert, G. A., Cepa, S. P., Surber, B. W., Machinist, J. M., Tich, N. R., Sullivan, J. P., Garvey, D. S., Fitzgerald, M. and Arneric, S. P., 1994, The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, Cynomolgus monkeys, and humans. Drug Metabolism and Disposition, 22, 788-798.
-
(1994)
Drug Metabolism and Disposition
, vol.22
, pp. 788-798
-
-
Rodrigues, A.D.1
Ferrero, J.L.2
Amann, M.T.3
Rotert, G.A.4
Cepa, S.P.5
Surber, B.W.6
Machinist, J.M.7
Tich, N.R.8
Sullivan, J.P.9
Garvey, D.S.10
Fitzgerald, M.11
Arneric, S.P.12
-
21
-
-
0033016501
-
Zaleplon pharmacokinetics and absolute bioavailability
-
Rosen, A. S., Fournie, P., Darwish, M., Danjou, P. and Troy, S. M., 1999, Zaleplon pharmacokinetics and absolute bioavailability. Biopharmaceutics and Drug Disposition, 20, 171-175.
-
(1999)
Biopharmaceutics and Drug Disposition
, vol.20
, pp. 171-175
-
-
Rosen, A.S.1
Fournie, P.2
Darwish, M.3
Danjou, P.4
Troy, S.M.5
-
22
-
-
0023248835
-
Pharmacokinetic interactions of cimetidine 1987
-
Somogyi, A. and Muirhead, M., 1987, Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics, 12, 321-366.
-
(1987)
Clinical Pharmacokinetics
, vol.12
, pp. 321-366
-
-
Somogyi, A.1
Muirhead, M.2
-
23
-
-
0028109342
-
Metabolism of coumarin and 7-ethoxycoumarin by rat, guinea pig. Cynomolgus monkey and human precision-cut liver slices
-
Steensma, A., Beamand, J. A., Walters, D. G., Price, R. J. and Lake, B. G., 1994, Metabolism of coumarin and 7-ethoxycoumarin by rat, guinea pig, Cynomolgus monkey and human precision-cut liver slices. Xenobiotica, 24, 893-907.
-
(1994)
Xenobiotica
, vol.24
, pp. 893-907
-
-
Steensma, A.1
Beamand, J.A.2
Walters, D.G.3
Price, R.J.4
Lake, B.G.5
-
24
-
-
0032456884
-
Clinically important pharmacokinetic drug-drug interactions: Role of cytochrome P450 enzymes
-
Tanaka, E., 1998, Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. Journal of Clinical Pharmacy and Therapeutics, 23, 403-416.
-
(1998)
Journal of Clinical Pharmacy and Therapeutics
, vol.23
, pp. 403-416
-
-
Tanaka, E.1
-
25
-
-
0000064691
-
Mass balance and pharmacokinetics of zaleplon, a non-benzodiazepine sedative/hypnotic, in man
-
Wu, W. H., Dicioccio, A. T., Demaio, W., Amorusi, P., Tonelli, A. P. and Mayer, P. R., 1996, Mass balance and pharmacokinetics of zaleplon, a non-benzodiazepine sedative/hypnotic, in man. Pharmaceutical Research, 13, S487.
-
(1996)
Pharmaceutical Research
, vol.13
-
-
Wu, W.H.1
Dicioccio, A.T.2
Demaio, W.3
Amorusi, P.4
Tonelli, A.P.5
Mayer, P.R.6
-
26
-
-
0023050157
-
Kinetic and inhibition studies on reduction of diphenyl sulphoxide by guinea pig liver aldehyde oxidase
-
Yoshihara, S. and Tatsumi, K., 1986, Kinetic and inhibition studies on reduction of diphenyl sulphoxide by guinea pig liver aldehyde oxidase. Archives of Biochemistry and Biophysics, 249, 8-14.
-
(1986)
Archives of Biochemistry and Biophysics
, vol.249
, pp. 8-14
-
-
Yoshihara, S.1
Tatsumi, K.2
|